Replies to post #47 on MyMD Pharmaceuticals Inc (MYMD)

[leifsmith]

The author of the Psychology Today article is associated with Johns Hopkins

Johns Hopkins is where most (or all?) MYMD-1 research occurs.

Thanks mrboom for the link to Dr. Adam Kaplin's article in Psychology Today:
https://www.psychologytoday.com/us/blog/normal-is-overrated/202105/the-coming-epidemic-covid-19-associated-depression

One paragraph about MYMD-1 from the article:

Like many of the most effective drugs in the medical arsenal, this is a synthetic alkaloid originally derived from a plant. It addresses immunometabolic dysregulation by modulating numerous pro-inflammatory cytokines, including, IL-6, IL-17A, and most importantly, TNF-a. Because TNF-a is located at the head of the cascade of molecular signals that induce inflammation, it, therefore, cuts off inflammation at its source.

Hard to overstate the significance of this.